牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

荣昌生物（688331）

6.1

综合诊断：6.1分打败了89%的股票！

卖出
减持
中性
增持
买入

短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
中期趋势：
回落整理中且下跌趋势有所减缓。
长期趋势：
已有395家主力机构披露2025-12-31报告期持股数据，持仓量总计7934.49万股，占流通A股48.88%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

6.0分

7.0分

6.0分

2.9分

6.9分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：6.0技术面打败了52%的股票技术面评分前10的股票

近期的平均成本为149.06元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。

技术面得分最高的股票

平均成本

近期的平均成本为149.06元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"149.06","date":1776329667,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势跑输大盘，跑输行业平均水平。

[{"date":"2026.04.17","stock":"-2.06","trade":"-1.25","ind":"-0.10"},{"date":"2026.04.16","stock":"2.86","trade":"0.56","ind":"0.70"},{"date":"2026.04.15","stock":"5.10","trade":"1.39","ind":"0.01"},{"date":"2026.04.14","stock":"-3.09","trade":"1.04","ind":"0.95"},{"date":"2026.04.13","stock":"7.98","trade":"0.23","ind":"0.06"},{"date":"2026.04.10","stock":"-1.68","trade":"1.34","ind":"0.51"},{"date":"2026.04.09","stock":"-2.62","trade":"-1.48","ind":"-0.72"},{"date":"2026.04.08","stock":"-0.12","trade":"1.96","ind":"2.70"},{"date":"2026.04.07","stock":"-4.99","trade":"0.21","ind":"0.26"},{"date":"2026.04.03","stock":"-0.55","trade":"-2.48","ind":"-1.00"},{"date":"2026.04.02","stock":"4.12","trade":"0.58","ind":"-0.74"},{"date":"2026.04.01","stock":"11.83","trade":"4.76","ind":"1.46"},{"date":"2026.03.31","stock":"-1.25","trade":"-0.80","ind":"-0.80"},{"date":"2026.03.30","stock":"5.52","trade":"0.87","ind":"0.24"},{"date":"2026.03.27","stock":"5.79","trade":"3.53","ind":"0.63"},{"date":"2026.03.26","stock":"0.72","trade":"-0.83","ind":"-1.09"},{"date":"2026.03.25","stock":"-0.40","trade":"0.43","ind":"1.30"},{"date":"2026.03.24","stock":"4.62","trade":"3.52","ind":"1.78"},{"date":"2026.03.23","stock":"-4.64","trade":"-5.93","ind":"-3.63"},{"date":"2026.03.20","stock":"-4.19","trade":"-1.88","ind":"-1.24"},{"date":"2026.03.19","stock":"-1.23","trade":"-2.16","ind":"-1.39"}]

荣昌生物,上证指数,生物制品指数

压力支撑

该股压力位为149.30元，支撑位为144.35元。

[{"text":"\u538b\u529b\u4f4d","value":"149.30","date":1776355200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"144.35","date":1776355200,"color":"0x0b52a1"}]

多空趋势

多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：7.0资金面打败了95%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金总体无进出。

更新时间：04月17日 20:31

机构今日流向(万元)	-1886.49	机构5日流向(万元)	-1003.42
机构10日流向(万元)	-5049.46	机构20日流向(万元)	-4655.06

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少1222.66万股，其中基金净减仓8家，主力净增仓119家，暂未发现中长期投资价值。

截止2025-12-31，共395家主力机构（基金393家，券商集合理财1家，一般法人1家），持仓量总计7934.49万股，占流通A股48.88%
其中，基金持仓与2025-06-30相比：
增仓：70家，增持 677.61万股
减仓：78家，减持 701.79万股
新出现在主力名单中：232家，持有2040.92万股
从主力名单中消失：113家，原持有3210.89万股

消息面诊股

诊断结果：6消息面打败了90%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	分红转增	不分配不转增	2026-03-28
一般消息	募资投向		2026-03-28
利好	业绩预告	预计扭亏	2026-01-31
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-12-31
一般消息	重大事项	关联交易	2025-12-03
一般消息	股东大会	临时股东大会	2025-11-14
一般消息	分红转增	不分配不转增	2025-08-23
一般消息	高管变动	取消监事会	2025-06-26
一般消息	高管变动	委员会调整	2025-05-26

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：2.9行业面打败了24%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.04.17","price":"-0.10","value":"-1.25"},{"date":"2026.04.16","price":"0.70","value":"0.56"},{"date":"2026.04.15","price":"0.01","value":"1.39"},{"date":"2026.04.14","price":"0.95","value":"1.04"},{"date":"2026.04.13","price":"0.06","value":"0.23"},{"date":"2026.04.10","price":"0.51","value":"1.34"},{"date":"2026.04.09","price":"-0.72","value":"-1.48"},{"date":"2026.04.08","price":"2.70","value":"1.96"},{"date":"2026.04.07","price":"0.26","value":"0.21"},{"date":"2026.04.03","price":"-1.00","value":"-2.48"},{"date":"2026.04.02","price":"-0.74","value":"0.58"},{"date":"2026.04.01","price":"1.46","value":"4.76"},{"date":"2026.03.31","price":"-0.80","value":"-0.80"},{"date":"2026.03.30","price":"0.24","value":"0.87"},{"date":"2026.03.27","price":"0.63","value":"3.53"},{"date":"2026.03.26","price":"-1.09","value":"-0.83"},{"date":"2026.03.25","price":"1.30","value":"0.43"},{"date":"2026.03.24","price":"1.78","value":"3.52"},{"date":"2026.03.23","price":"-3.63","value":"-5.93"},{"date":"2026.03.20","price":"-1.24","value":"-1.88"},{"date":"2026.03.19","price":"-1.39","value":"-2.16"}]

上证指数,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	赛伦生物	52.42%	15.55%	6.0分
2	君实生物	35.17%	18.28%	6.3分
3	诺诚健华	27.91%	6.61%	5.9分
4	三生国健	26.28%	4.33%	6.0分
5	近岸蛋白	23.26%	14.63%	5.8分
6	荣昌生物	23.21%	10.80%	6.1分
7	-	22.18%	-2.75%	分
8	艾迪药业	20.55%	4.76%	5.5分
9	智翔金泰	18.01%	4.04%	5.5分
10	科兴制药	17.78%	3.46%	5.3分
11	通化东宝	16.00%	1.91%	5.3分
12	昊帆生物	14.50%	5.63%	6.1分
13	迈威生物	14.47%	2.27%	4.8分
14	百普赛斯	13.78%	-1.66%	4.8分
15	神州细胞	12.45%	5.61%	5.1分
16	赛升药业	9.65%	4.19%	5.0分
17	甘李药业	6.37%	1.61%	5.5分
18	-	6.03%	2.71%	分
19	义翘神州	5.53%	1.98%	5.4分
20	*ST双成	5.07%	6.38%	6.5分
21	我武生物	4.86%	2.02%	4.8分
22	凯因科技	4.79%	-0.56%	4.8分
23	安科生物	4.44%	0.30%	5.3分
24	康辰药业	3.85%	2.36%	5.8分
25	华兰疫苗	3.70%	0.25%	5.6分
26	万泽股份	3.62%	-4.84%	6.0分
27	百奥泰	1.68%	-0.17%	5.0分
28	沃森生物	0.56%	-0.80%	4.3分
29	华兰生物	0.53%	0.87%	5.6分
30	康华生物	0.08%	4.75%	5.0分
31	康希诺	-0.04%	7.37%	5.3分
32	康弘药业	-0.11%	-5.10%	4.5分
33	*ST四环	-0.33%	2.71%	5.7分
34	康泰生物	-0.71%	-0.78%	4.2分
35	金迪克	-1.01%	0.57%	4.4分
36	辽宁成大	-1.10%	-1.19%	5.7分
37	ST未名	-1.29%	3.52%	4.4分
38	西藏药业	-2.33%	-0.88%	4.9分
39	成大生物	-2.60%	-1.02%	4.4分
40	长春高新	-2.64%	0.72%	3.9分
41	-	-2.68%	-1.11%	分
42	智飞生物	-2.70%	-1.65%	4.6分
43	天坛生物	-4.11%	1.88%	5.0分
44	欧林生物	-4.56%	0.76%	5.1分
45	特宝生物	-4.64%	0.03%	4.9分
46	百克生物	-5.22%	-1.89%	4.2分
47	诺唯赞	-5.23%	-5.79%	4.3分
48	禾元生物	-5.40%	0.21%	4.2分
49	博雅生物	-5.80%	-0.05%	4.8分
50	卫光生物	-5.82%	0.48%	5.4分
51	派林生物	-6.65%	0.70%	5.0分
52	上海莱士	-6.86%	-0.70%	5.2分
53	博晖创新	-6.86%	-3.72%	4.3分
54	东宝生物	-7.34%	-3.46%	4.6分
55	优宁维	-10.18%	-0.46%	5.1分

<上一页 1 2 3 4 5...10 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：6.9基本面打败了90%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：弱（27.5分）

基本面得分最高的股票

[ 截止日期：2025-12-31 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/71 ， 7/71。

[{"date":"2025-12-31","value":"25.37","vol":"3.65"},{"date":"2025-09-30","value":"-25.58","vol":"-9.78"},{"date":"2025-06-30","value":"-20.70","vol":"-0.61"},{"date":"2025-03-31","value":"-13.53","vol":"0.46"},{"date":"2024-12-31","value":"-54.15","vol":"-0.68"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
净资产收益率(%)	25.37	-25.58	-20.70	-13.53	-54.15
行业(%)	3.65	-9.78	-0.61	0.46	-0.68

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-12-31","value":"87.28","vol":"70.51"},{"date":"2025-09-30","value":"84.27","vol":"67.61"},{"date":"2025-06-30","value":"84.06","vol":"68.28"},{"date":"2025-03-31","value":"83.26","vol":"68.43"},{"date":"2024-12-31","value":"80.36","vol":"69.85"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
销售毛利率(%)	87.28	84.27	84.06	83.26	80.36
行业(%)	70.51	67.61	68.28	68.43	69.85

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 4/71 ， 3/71。

[{"date":"2025-12-31","value":"89.36","vol":"44.41"},{"date":"2025-09-30","value":"42.27","vol":"45.25"},{"date":"2025-06-30","value":"48.02","vol":"6902.04"},{"date":"2025-03-31","value":"59.17","vol":"6125.27"},{"date":"2024-12-31","value":"58.54","vol":"47.35"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
营业收入同比增长率(%)	89.36	42.27	48.02	59.17	58.54
行业(%)	44.41	45.25	6902.04	6125.27	47.35

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-12-31","value":"148.33","vol":"44.06"},{"date":"2025-09-30","value":"48.60","vol":"44.80"},{"date":"2025-06-30","value":"42.40","vol":"5.44"},{"date":"2025-03-31","value":"27.16","vol":"-8.46"},{"date":"2024-12-31","value":"2.84","vol":"-9.81"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
净利润同比增长率(%)	148.33	48.60	42.40	27.16	2.84
行业(%)	44.06	44.80	5.44	-8.46	-9.81

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 4/71 ， 20/71。

[{"date":"2025-12-31","value":"0.51","vol":"0.33"},{"date":"2025-09-30","value":"0.30","vol":"0.22"},{"date":"2025-06-30","value":"0.19","vol":"0.14"},{"date":"2025-03-31","value":"0.10","vol":"0.06"},{"date":"2024-12-31","value":"0.31","vol":"0.29"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
总资产周转率(次)	0.51	0.30	0.19	0.10	0.31
行业(次)	0.33	0.22	0.14	0.06	0.29

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-12-31","value":"0.63","vol":"1.24"},{"date":"2025-09-30","value":"0.41","vol":"0.92"},{"date":"2025-06-30","value":"0.27","vol":"0.56"},{"date":"2025-03-31","value":"0.14","vol":"0.26"},{"date":"2024-12-31","value":"0.48","vol":"1.17"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
存货增长率(次)	0.63	0.41	0.27	0.14	0.48
行业(次)	1.24	0.92	0.56	0.26	1.17

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 18/71 ， 4/71。

[{"date":"2025-12-31","value":"-10.72","vol":"3.86"},{"date":"2025-09-30","value":"74.39","vol":"1.84"},{"date":"2025-06-30","value":"-10.00","vol":"-1377.61"},{"date":"2025-03-31","value":"-35.80","vol":"-46.99"},{"date":"2024-12-31","value":"-54.96","vol":"-11.33"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
现金流量净额/营业收入	-10.72	74.39	-10.00	-35.80	-54.96
行业	3.86	1.84	-1377.61	-46.99	-11.33

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-12-31","value":"0.62","vol":"1.49"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.75","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.88","vol":"2.01"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
资本支出／折旧和摊销	0.62	-	0.75	-	0.88
行业	1.49	0.00	1.59	0.00	2.01

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/71 ， 2/71。

[{"date":"2025-12-31","value":"1.43","vol":"5.79"},{"date":"2025-09-30","value":"0.96","vol":"6.00"},{"date":"2025-06-30","value":"1.06","vol":"6.64"},{"date":"2025-03-31","value":"0.92","vol":"7.75"},{"date":"2024-12-31","value":"1.05","vol":"6.72"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
流动比率	1.43	0.96	1.06	0.92	1.05
行业	5.79	6.00	6.64	7.75	6.72

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-12-31","value":"1.15","vol":"4.42"},{"date":"2025-09-30","value":"0.66","vol":"4.84"},{"date":"2025-06-30","value":"0.74","vol":"5.30"},{"date":"2025-03-31","value":"0.56","vol":"6.35"},{"date":"2024-12-31","value":"0.64","vol":"5.40"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
速动比率	1.15	0.66	0.74	0.56	0.64
行业	4.42	4.84	5.30	6.35	5.40

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 1/71 ， 4/71。

[{"date":"2025-12-31","value":"50.21","vol":"26.76"},{"date":"2025-09-30","value":"61.18","vol":"28.18"},{"date":"2025-06-30","value":"59.70","vol":"26.73"},{"date":"2025-03-31","value":"66.62","vol":"26.03"},{"date":"2024-12-31","value":"63.88","vol":"25.81"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
资产负债率(%)	50.21	61.18	59.70	66.62	63.88
行业(%)	26.76	28.18	26.73	26.03	25.81

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-12-31","value":"1.01","vol":"0.92"},{"date":"2025-09-30","value":"1.58","vol":"0.58"},{"date":"2025-06-30","value":"1.48","vol":"1.11"},{"date":"2025-03-31","value":"2.00","vol":"0.78"},{"date":"2024-12-31","value":"1.77","vol":"0.87"}]

	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
产权比率 (%)	1.01	1.58	1.48	2.00	1.77
行业(%)	0.92	0.58	1.11	0.78	0.87

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
西部证券	2026-04-10	买入
东北证券	2026-04-09	买入	买入
华泰证券	2026-04-04	买入	买入
东海证券	2026-04-02	买入
国投证券	2026-04-01	买入
国金证券	2026-03-30	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"-9.99","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-15.11","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-14.68","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"7.10","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"29.80","blueLineValue":"5.28","type":"YC"}]

[荣昌生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]